Pharma channel feed – Endpoints News

Pharma channel feed

Sanofi buys into radiopharmaceutical field with $110M upfront, going after space held by Novartis

8 months ago

J&J expands Tremfya into IBD with new FDA approval

8 months ago

FDA criticizes AbbVie's 'misleading' ad with Serena Williams

8 months ago

FDA is poised to pull Ocaliva as adcomm documents question post-approval study results

8 months ago

Adicet follows other cell therapy biotechs in autoimmune pivot

8 months ago

Corrected: Optum’s biosimilar business to go after brand-name Humira, Stelara in 2025

8 months ago

Lilly's weekly insulin hits primary endpoints in two more late-stage diabetes studies

8 months ago

Roche's dual GLP-1/GIP results show promising weight loss, but also high rates of vomiting

8 months ago

GSK to shut down UK antibiotic facility following end of Sandoz contract

8 months ago

Updated: Viridian reveals first Phase 3 eye disease data in bid to compete with Tepezza

8 months ago

Bayer's treatment for menopause symptoms hits primary endpoints in third late-stage trial

8 months ago

FDA advisors question whether Iterum's application for a UTI antibacterial is restrictive enough

8 months ago

GSK says long-acting asthma hopeful significantly cut attacks

8 months ago

Lilly again hires from within for CFO post, elevating 23-year company veteran

8 months ago

Federal judge rejects pharma industry’s request to halt Maryland’s 340B law

8 months ago

Non-viral delivery startup Vesigen Therapeutics trims staff as it evaluates 'strategic options'

8 months ago

Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston

8 months ago

FDA grants full approval to Travere’s Filspari for IgAN

8 months ago

BridgeBio sticks to script for ATTR-CM as Alnylam cleans up ‘typo’ snafu

8 months ago

Exclusive: Lilly-backed OrsoBio raises $67M for slate of obesity drugs as combinations take root

8 months ago

FDA raises antimicrobial resistance concerns ahead of adcomm for Iterum's UTI treatment

8 months ago

J&J increases talc settlement by $1.1B after negotiating with plaintiffs, lawyers say

8 months ago

Ocaliva will continue to be available in the EU following European court's decision

8 months ago

Cigna offers discounted Stelara biosimilar, building on Humira move

8 months ago

First page Previous page 34 35 363738 39 40 Next page Last page